KULABAŞ, N. Et Al. 2021. Evaluation of molnupiravir analogues as novel coronavirus (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors - an in silico docking and ADMET simulation study. JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.6 , 967-981.

KULABAŞ, N., YEŞİL, T., & KÜÇÜKGÜZEL, İ., (2021). Evaluation of molnupiravir analogues as novel coronavirus (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors - an in silico docking and ADMET simulation study. JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.6, 967-981.

KULABAŞ, NECLA, TUĞÇE YEŞİL EKİCİ, And İLKAY KÜÇÜKGÜZEL. "Evaluation of molnupiravir analogues as novel coronavirus (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors - an in silico docking and ADMET simulation study," JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.6, 967-981, 2021

KULABAŞ, NECLA Et Al. "Evaluation of molnupiravir analogues as novel coronavirus (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors - an in silico docking and ADMET simulation study." JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.6, pp.967-981, 2021

KULABAŞ, N. YEŞİL, T. And KÜÇÜKGÜZEL, İ. (2021) . "Evaluation of molnupiravir analogues as novel coronavirus (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors - an in silico docking and ADMET simulation study." JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.6, pp.967-981.

@article{article, author={NECLA KULABAŞ Et Al. }, title={Evaluation of molnupiravir analogues as novel coronavirus (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors - an in silico docking and ADMET simulation study}, journal={JOURNAL OF RESEARCH IN PHARMACY}, year=2021, pages={967-981} }